$CRTG
CORETEC GROUP INC.

2021 Form 10-K Financial Statement

#000143774922006796 Filed on March 21, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.615M $248.7K $1.029M
YoY Change 445.61% -3.43% -30.78%
% of Gross Profit
Research & Development $470.0K $30.00K $151.9K
YoY Change 209.48% 49.55% 2.01%
% of Gross Profit
Depreciation & Amortization $0.00 $20.06K $126.00
YoY Change -100.0% -0.94% -83.33%
% of Gross Profit
Operating Expenses $470.0K $283.3K $151.9K
YoY Change 209.48% 2.09% 2.01%
Operating Profit
YoY Change
Interest Expense $229.5K -$307.6K $665.2K
YoY Change -65.5% 436.86% 131.54%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.269M -$590.9K -$1.845M
YoY Change 239.78% 76.49% -0.51%
Income Tax
% Of Pretax Income
Net Earnings -$6.269M -$590.9K -$1.845M
YoY Change 239.78% 76.49% -0.51%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$25.70K -$2.805K -$9.103K
COMMON SHARES
Basic Shares Outstanding 244.0M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.053M $22.22K $22.22K
YoY Change 18141.81% -61.79% -61.79%
Cash & Equivalents $22.22K
Short-Term Investments
Other Short-Term Assets $133.5K $180.0K $180.0K
YoY Change -25.82% 102.61% 102.61%
Inventory
Prepaid Expenses $180.0K
Receivables
Other Receivables
Total Short-Term Assets $4.187M $202.2K $202.2K
YoY Change 1970.84% 37.57% 37.57%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change -100.0%
Goodwill $166.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $16.34K $18.95K $18.95K
YoY Change -13.77% 429.33% 429.33%
Total Long-Term Assets $1.172M $1.244M $1.244M
YoY Change -5.79% -4.96% -4.97%
TOTAL ASSETS
Total Short-Term Assets $4.187M $202.2K $202.2K
Total Long-Term Assets $1.172M $1.244M $1.244M
Total Assets $5.359M $1.446M $1.446M
YoY Change 270.55% -0.67% -0.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $307.1K $400.0K $396.0K
YoY Change -22.45% -35.05% -35.69%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $46.58K $46.58K
YoY Change -100.0% 19.01% 19.01%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $307.1K $442.6K $442.6K
YoY Change -30.61% -32.42% -32.42%
LONG-TERM LIABILITIES
Long-Term Debt $1.188M $266.6K $266.6K
YoY Change 345.43% 121.22% 121.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.188M $266.6K $266.6K
YoY Change 345.43% 121.22% 121.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $307.1K $442.6K $442.6K
Total Long-Term Liabilities $1.188M $266.6K $266.6K
Total Liabilities $1.495M $709.2K $709.2K
YoY Change 110.75% -8.55% -8.54%
SHAREHOLDERS EQUITY
Retained Earnings -$7.339M
YoY Change 33.58%
Common Stock $42.75K
YoY Change 10.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.864M $737.0K $737.0K
YoY Change
Total Liabilities & Shareholders Equity $5.359M $1.446M $1.446M
YoY Change 270.55% -0.67% -0.67%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$6.269M -$590.9K -$1.845M
YoY Change 239.78% 76.49% -0.51%
Depreciation, Depletion And Amortization $0.00 $20.06K $126.00
YoY Change -100.0% -0.94% -83.33%
Cash From Operating Activities -$1.114M -$318.2K -$1.353M
YoY Change -17.64% -17.09% 120.9%
INVESTING ACTIVITIES
Capital Expenditures -$12.01K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$12.01K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.913M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.157M 316.8K $1.317M
YoY Change 291.61% -26.88% 97.56%
NET CHANGE
Cash From Operating Activities -$1.114M -318.2K -$1.353M
Cash From Investing Activities -12.01K
Cash From Financing Activities $5.157M 316.8K $1.317M
Net Change In Cash $4.031M -1.440K -$35.93K
YoY Change -11319.34% -102.91% -166.36%
FREE CASH FLOW
Cash From Operating Activities -$1.114M -$318.2K -$1.353M
Capital Expenditures -$12.01K
Free Cash Flow -$1.102M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Tulsa, Oklahoma
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
254055581
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
254055581
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213751145
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213751145
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q4 us-gaap Cash
Cash
4053327 USD
CY2020Q4 us-gaap Cash
Cash
22219 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133491 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
179963 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4186818 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
202182 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
989604 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1059026 USD
CY2021Q4 us-gaap Goodwill
Goodwill
166000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
166000 USD
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16343 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18946 USD
CY2021Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1171947 USD
CY2020Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1243972 USD
CY2021Q4 us-gaap Assets
Assets
5358765 USD
CY2020Q4 us-gaap Assets
Assets
1446154 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
46580 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
307096 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
396019 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
307096 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
442599 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1187518 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
266598 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1494614 USD
CY2020Q4 us-gaap Liabilities
Liabilities
709197 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
69 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
69 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
50809 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
42750 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17295262 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8033313 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13481989 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7339175 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3864151 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5358765 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1446154 USD
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
469996 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
151864 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5615038 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1029136 USD
CY2021 us-gaap Interest Expense
InterestExpense
229525 USD
CY2020 us-gaap Interest Expense
InterestExpense
665232 USD
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
6314559 USD
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
1846232 USD
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
45620 USD
CY2020 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1250 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6268939 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1844982 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.026
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.009
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
243964924
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
202680171
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
680465 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
135705 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1049826 USD
CY2020 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
11470 USD
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
61977 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
92496 USD
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
550000 USD
CY2020 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1844982 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957 USD
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
265458 USD
CY2021 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
94851 USD
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
323223 USD
CY2021 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4913200 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
62785 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4599391 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6268939 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3864151 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6268939 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-1844982 USD
CY2021 us-gaap Depreciation
Depreciation
0 USD
CY2020 us-gaap Depreciation
Depreciation
126 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
81429 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80229 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
95661 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
572091 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4599391 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
92496 USD
CY2021 crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
323223 USD
CY2020 crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
61977 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-46472 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
91142 USD
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-2603 USD
CY2020 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
15371 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5930 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-208326 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1114230 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1352902 USD
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12007 USD
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
90505 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
69709 USD
CY2021 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
334650 USD
CY2020 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
1386681 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4913200 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</p>
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5157345 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1316972 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4031108 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35930 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22219 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58149 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4053327 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22219 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
92434 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
84366 USD
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
265458 USD
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
550000 USD
CY2021 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
600 USD
CY2020 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
360 USD
CY2021 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
94851 USD
CY2020 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
11470 USD
CY2021 crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
0 USD
CY2020 crtg Recognition Of Beneficial Conversion Feature
RecognitionOfBeneficialConversionFeature
1049826 USD
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61270973
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
236266997
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
266598 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7339175 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1187518 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
266598 USD
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 pure
CY2021 crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
5000000
CY2020 crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
3000000
CY2021 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
3000000
CY2020 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
1800000
CY2021 crtg Convertible Preferred Stock Volume Weighted Average Price Trigger
ConvertiblePreferredStockVolumeWeightedAveragePriceTrigger
15.00
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2190000
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0520
CY2021 crtg Class Of Warrant Or Right Issued Monthly
ClassOfWarrantOrRightIssuedMonthly
88914000
CY2021 crtg Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.0812
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
142604000
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0515
CY2021 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P3Y8M8D
CY2021Q4 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
6906182 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 pure
crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
8000000
crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
4800000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1500000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.057
CY2021Q3 crtg Stock Cancelled And Reissued During Period
StockCancelledAndReissuedDuringPeriod
23000000
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.105
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4599391 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
92496 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
13740 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
25592 USD
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
53711609
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P4Y2M1D
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
53461609

Files In Submission

Name View Source Status
0001437749-22-006796-index-headers.html Edgar Link pending
0001437749-22-006796-index.html Edgar Link pending
0001437749-22-006796.txt Edgar Link pending
0001437749-22-006796-xbrl.zip Edgar Link pending
crtg-20211231.xsd Edgar Link pending
crtg-20211231_cal.xml Edgar Link unprocessable
crtg-20211231_def.xml Edgar Link unprocessable
crtg-20211231_lab.xml Edgar Link unprocessable
crtg-20211231_pre.xml Edgar Link unprocessable
crtg20211231_10k.htm Edgar Link pending
crtg20211231_10k_htm.xml Edgar Link completed
ex_347906.htm Edgar Link pending
ex_347907.htm Edgar Link pending
ex_347908.htm Edgar Link pending
ex_347909.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending